Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daniel Pörner, Sibylle Von Vietinghoff, Jacob Nattermann, Christian P Strassburg & Philipp Lutz. (2021) Advances in the pharmacological management of bacterial peritonitis. Expert Opinion on Pharmacotherapy 22:12, pages 1567-1578.
Read now
Read now
Articles from other publishers (18)
Ibrahim Mohammed Alrowiyti & Joanne Bargman. (2023) A Review of Residual Kidney Function in Peritoneal Dialysis Patients. Indian Journal of Nephrology.
Crossref
Crossref
Marek Zadrożniak, Marcin Szymański & Jarogniew J. Łuszczki. (2023) N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease. International Journal of Molecular Sciences 24:8, pages 7596.
Crossref
Crossref
Santosh Varughese, Phanidhar Mogga & Priya Anantharaman. 2023. Diagnosis and Management of Complications of Peritoneal Dialysis related Peritonitis. Diagnosis and Management of Complications of Peritoneal Dialysis related Peritonitis
61
80
.
Philip Kam-Tao Li, Kai Ming Chow, Yeoungjee Cho, Stanley Fan, Ana E Figueiredo, Tess Harris, Talerngsak Kanjanabuch, Yong-Lim Kim, Magdalena Madero, Jolanta Malyszko, Rajnish Mehrotra, Ikechi G Okpechi, Jeff Perl, Beth Piraino, Naomi Runnegar, Isaac Teitelbaum, Jennifer Ka-Wah Wong, Xueqing Yu & David W Johnson. (2022) ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 42:2, pages 110-153.
Crossref
Crossref
Yasuhiko Ito, Munekazu Ryuzaki, Hitoshi Sugiyama, Tadashi Tomo, Akihiro C. Yamashita, Yuichi Ishikawa, Atsushi Ueda, Yoshie Kanazawa, Yoshihiko Kanno, Noritomo Itami, Minoru Ito, Hideki Kawanishi, Masaaki Nakayama, Kazuhiko Tsuruya, Hideki Yokoi, Mizuya Fukasawa, Hiroyuki Terawaki, Kei Nishiyama, Hiroshi Hataya, Kenichiro Miura, Riku Hamada, Hyogo Nakakura, Motoshi Hattori, Hidemichi Yuasa & Hidetomo Nakamoto. (2021) Peritoneal Dialysis Guidelines 2019 Part 1 (Position paper of the Japanese Society for Dialysis Therapy). Renal Replacement Therapy 7:1.
Crossref
Crossref
Cheuk-Chun Szeto, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Phyllis Mei-Shan Cheng, Ka-Bik Lai, Wing-Fai Pang, Kai-Ming Chow, Chi-Bon Leung & Philip Kam-Tao Li. (2021) Extended antibiotic therapy for the prevention of relapsing and recurrent peritonitis in peritoneal dialysis patients: a randomized controlled trial. Clinical Kidney Journal 14:3, pages 991-997.
Crossref
Crossref
Mehmet Akif Somdaş, İnayet Güntürk, Esra Balcıoğlu, Deniz Avcı, Cevat Yazıcı & Saim Özdamar. (2020) Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy. Brazilian Journal of Otorhinolaryngology 86:1, pages 30-37.
Crossref
Crossref
Cheuk-Chun Szeto & Philip Kam-Tao Li. (2019) Peritoneal Dialysis–Associated Peritonitis. Clinical Journal of the American Society of Nephrology 14:7, pages 1100-1105.
Crossref
Crossref
Cheuk-Chun Szeto & Philip Kam-Tao Li. 2019. Chronic Kidney Disease, Dialysis, and Transplantation. Chronic Kidney Disease, Dialysis, and Transplantation
509
519.e5
.
Kathleen C. M. Campbell & Colleen G. Le Prell. (2018) Drug-Induced Ototoxicity: Diagnosis and Monitoring. Drug Safety 41:5, pages 451-464.
Crossref
Crossref
Alperen Vural, İsmail Koçyiğit, Furkan Şan, Eray Eroğlu, İbrahim Ketenci, Aydin Ünal, Bülent Tokgöz & Yaşar Ünlü. (2018) Long-Term Protective Effect of N-Acetylcysteine against Amikacin-Induced Ototoxicity in End-Stage Renal Disease: A Randomized Trial. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 38:1, pages 57-62.
Crossref
Crossref
Velina S. Atanasova, Qiujie Jiang, Marco Prisco, Christina Gruber, Josefina Piñón Hofbauer, Mei Chen, Cristina Has, Leena Bruckner-Tuderman, John A. McGrath, Jouni Uitto & Andrew P. South. (2017) Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology 137:9, pages 1842-1849.
Crossref
Crossref
Philip Kam-Tao Li, Cheuk Chun Szeto, Beth Piraino, Javier de Arteaga, Stanley Fan, Ana E. Figueiredo, Douglas N. Fish, Eric Goffin, Yong-Lim Kim, William Salzer, Dirk G. Struijk, Isaac Teitelbaum & David W. Johnson. (2016) ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 36:5, pages 481-508.
Crossref
Crossref
Ismail Kocyigit, Alperen Vural, Aydin Unal, Murat Hayri Sipahioglu, Hasan Esat Yucel, Samet Aydemir, Cevat Yazici, M. İlhan Sahin, Oktay Oymak & Bulent Tokgoz. (2014) Preventing amikacin related ototoxicity with N-acetylcysteine in patients undergoing peritoneal dialysis. European Archives of Oto-Rhino-Laryngology 272:10, pages 2611-2620.
Crossref
Crossref
Emily C. Tucker & David L. Gordon. 2012. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
399
425
.
B. Tokgoz, C. Ucar, I. Kocyigit, M. Somdas, A. Unal, A. Vural, M. Sipahioglu, O. Oymak & C. Utas. (2011) Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis. Nephrology Dialysis Transplantation 26:12, pages 4073-4078.
Crossref
Crossref
David W. Johnson. (2011) Do antibiotic levels need to be followed in treating peritoneal dialysis‐Associated peritonitis?. Seminars in Dialysis 24:4, pages 445-446.
Crossref
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:9, pages i-xiii.
Crossref
Crossref